Response to "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence".
Hum Vaccin Immunother
; 20(1): 2386225, 2024 Dec 31.
Article
in En
| MEDLINE
| ID: mdl-39110666
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bibliometrics
/
Immunotherapy, Adoptive
/
Hematologic Neoplasms
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2024
Document type:
Article
Affiliation country:
China